October 2, 2020 October 2, 2020Categories Trial ResultsTrial Results: For women with breast cancer in the TAILORx trial, cognitive decline from chemo was early and abrupt but did not get worse over time. Cognition also declined in the group on hormone therapy alone.Cognitive loss—or ‘brain fog’—involves memory problems, a lack of mental clarity, and difficulty keeping one’s focus. Cancer-related brain fog is common during treatment. This study dispels the idea that it is only from chemotherapy.
February 12, 2020 February 12, 2020Categories Trial ResultsTrial Results: New TAILORx data shows chemotherapy benefit for women at high risk of breast cancer recurrenceThe TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.
